Genetic epidemiology of resistance to M. tuberculosis Infection: importance of study design and recent findings

被引:1
|
作者
Stein, Catherine M. [1 ,2 ]
机构
[1] Case Western Reserve Univ, Dept Populat & Quantitat Hlth Sci, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Dept Med, Div Infect Dis & HIV Med, Cleveland, OH 44106 USA
关键词
MYCOBACTERIUM-TUBERCULOSIS; SUSCEPTIBILITY; EXPRESSION; LOCUS;
D O I
10.1038/s41435-023-00204-z
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Resistance to M. tuberculosis, often referred to as "RSTR" in the literature, is being increasingly studied because of its potential relevance as a clinical outcome in vaccine studies. This review starts by addressing the importance of epidemiological characterization of this phenotype, and ongoing challenges in that characterization. Then, this review summarizes the extant genetic and genomic studies of this phenotype, including heritability studies, candidate gene studies, and genome-wide association studies, as well as whole transcriptome studies. Findings from recent studies that used longitudinal characterization of the RSTR phenotype are compared to those using a cross-sectional definition, and the challenges of using tuberculin skin test and interferon-gamma release assay are discussed. Finally, future directions are proposed. Since this is a rapidly evolving area of public health significance, this review will help frame future research questions and study designs.
引用
收藏
页码:117 / 123
页数:7
相关论文
共 50 条
  • [1] Genetic epidemiology of resistance to M. tuberculosis Infection: importance of study design and recent findings
    Catherine M. Stein
    [J]. Genes & Immunity, 2023, 24 : 117 - 123
  • [2] Genetic Epidemiology of Tuberculosis Susceptibility: Impact of Study Design
    Stein, Catherine M.
    [J]. PLOS PATHOGENS, 2011, 7 (01)
  • [3] Concomitant immunity to M. tuberculosis infection
    Joslyn, Louis R.
    Flynn, JoAnne L.
    Kirschner, Denise E.
    Linderman, Jennifer J.
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [4] Concomitant immunity to M. tuberculosis infection
    Louis R. Joslyn
    JoAnne L. Flynn
    Denise E. Kirschner
    Jennifer J. Linderman
    [J]. Scientific Reports, 12
  • [5] The evolution of drug resistance in M. tuberculosis
    Farhat, Maha
    Shapiro, Jesse
    Sultana, Razvan
    Sabeti, Pardis
    Murray, Megan
    [J]. TUBERCULOSIS, 2013, 93 (01) : 113 - 113
  • [6] Importance of Study Design and Phenotype Definition in Ongoing Studies of Resistance to Latent Mycobacterium tuberculosis Infection
    Stein, Catherine M.
    Mayanja-Kizza, Harriet
    Hawn, Thomas R.
    Boom, W. Henry
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2020, 221 (06): : 1025 - 1026
  • [7] Ocular mycobacteriosis—dual infection of M. tuberculosis complex with M. fortuitum and M. bovis
    Sharma K.
    Gautam N.
    Sharma M.
    Dogra M.
    Bajgai P.
    Tigari B.
    Sharma A.
    Gupta V.
    Sharma S.P.
    Singh R.
    [J]. Journal of Ophthalmic Inflammation and Infection, 7 (1)
  • [8] Human Tuberculosis II. M. tuberculosis Mechanisms of Genetic and Phenotypic Resistance to Anti-Tuberculosis Drugs
    Sgaragli, Giampietro
    Frosini, Maria
    [J]. CURRENT MEDICINAL CHEMISTRY, 2016, 23 (12) : 1186 - 1216
  • [9] Advances in molecular epidemiology: tracking M. Tuberculosis strains
    Borrell, S.
    [J]. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2011, 16 : 50 - 50
  • [10] Difference in virulence and resistance to pyrazinamide between M. bovis and M. tuberculosis
    van Loenhout-Rooyackers, JH
    [J]. NETHERLANDS JOURNAL OF MEDICINE, 1999, 55 (03): : 163 - 163